Ascelia Pharma AB (publ) Financial Flexibility Index
Ascelia Pharma AB (publ) financial flexibility index. Ascelia Pharma AB (publ) (ACE) has a Financial Flexibility Index of -0.71x as of September 2025. Free cash flow of Skr-15.60 Million (operating CF Skr-15.66 Million minus capex Skr57.00K) represents -1% of total liabilities (Skr22.01 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Ascelia Pharma AB (publ) (2017–2024)
Financial flexibility index of Ascelia Pharma AB (publ) from 2017 to 2024. Historical Financial Flexibility Index trend for Ascelia Pharma AB (publ) across 8 annual periods. Explore Ascelia Pharma AB (publ) (ACE) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Ascelia Pharma AB (publ) Financial Flexibility Index by Year (2017–2024)
Ascelia Pharma AB (publ) financial flexibility index by year from 2017 to 2024. Year-by-year free cash flow to debt coverage for Ascelia Pharma AB (publ). For the full cash flow conversion analysis, see how efficiently does Ascelia Pharma AB (publ) generate cash.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.01x | Skr-62.84 Million | Skr-62.84 Million | Skr61.98 Million | — |
| 2023 | 0.00x | Skr0.00 | Skr-126.79 Million | Skr12.74 Million | ▲ +100.0% |
| 2022 | -3.32x | Skr-125.20 Million | Skr-125.26 Million | Skr37.71 Million | ▲ +26.9% |
| 2021 | -4.54x | Skr-116.52 Million | Skr-116.56 Million | Skr25.66 Million | ▼ -3.0% |
| 2020 | -4.41x | Skr-85.13 Million | Skr-85.53 Million | Skr19.32 Million | ▼ -58.8% |
| 2019 | -2.77x | Skr-36.52 Million | Skr-36.92 Million | Skr13.16 Million | ▼ -5.1% |
| 2018 | -2.64x | Skr-29.94 Million | Skr-30.33 Million | Skr11.35 Million | ▲ +43.3% |
| 2017 | -4.65x | Skr-20.56 Million | Skr-20.96 Million | Skr4.42 Million | — |